New program aims to help black men with HIV stay healthy and connected
NCT ID NCT06315218
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called NPOWER365 for Black men who have sex with men and are living with HIV. The program uses a smartphone app, online forums, and resource referrals to help with medication adherence, mental health, and access to care. About 350 participants in the Atlanta area will be followed for up to 6 months to see if the program improves daily HIV medication use and reduces depression and anxiety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NPOWER365 HIV care intervention (behavioral program with mobile health features, online forums, and resource referrals)
What this could lead to
If it works, this could point toward a scalable way to improve HIV medication adherence and mental health for Black men who have sex with men.
What could go wrong
This is a behavioral intervention study, not a drug trial. Results may not apply outside the Atlanta area, and adherence improvements may not last long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••